Date | Name | Shares | Transaction | Value |
Apr 15, 2025
| David H. Keyte Director |
103,164
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 15, 2025
| Peter A. Dea Director |
59,249
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 15, 2025
| Janine Marie McArdle Director |
72,865
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 15, 2025
| John C. Mollenkopf Director |
97,007
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 15, 2025
| W. Howard Keenan Director |
148,132
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 15, 2025
| Jeffrey S. Munoz Director |
3,845
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 15, 2025
| Brooks J. Klimley Director |
78,645
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 15, 2025
| Nancy E. Chisholm Director |
24,649
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 11, 2025
| Sheri L. Pearce See Remarks |
157,899
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $16.46 per share |
2,599,017.54
|
Mar 11, 2025
| Sheri L. Pearce See Remarks |
176,389
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 11, 2025
| Brendan E. Krueger See Remarks |
603,959
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $16.46 per share |
9,941,165.14
|
Mar 11, 2025
| Brendan E. Krueger See Remarks |
642,786
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 11, 2025
| Yvette K. Schultz See Remarks |
601,390
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $16.46 per share |
9,898,879.40
|
Mar 11, 2025
| Yvette K. Schultz See Remarks |
649,923
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 11, 2025
| Michael N. Kennedy See Remarks; Director |
1,408,394
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $16.46 per share |
23,182,165.24
|
Mar 11, 2025
| Michael N. Kennedy See Remarks; Director |
1,487,896
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 11, 2025
| Paul M. Rady Chief Executive Officer; Director |
3,223,608
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $16.46 per share |
53,060,587.68
|
Mar 11, 2025
| Paul M. Rady Chief Executive Officer; Director |
3,408,495
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|